0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hemostat Powder Market Research Report 2026
Published Date: 2026-02-06
|
Report Code: QYRE-Auto-13D4377
Home | Market Reports
Global Hemostat Powder Market Research Report 2021
BUY CHAPTERS

Global Hemostat Powder Market Research Report 2026

Code: QYRE-Auto-13D4377
Report
2026-02-06
Pages:127
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hemostat Powder Market Size

The global Hemostat Powder market was valued at US$ 440 million in 2025 and is anticipated to reach US$ 600 million by 2032, at a CAGR of 4.6% from 2026 to 2032.

Hemostat Powder Market

Hemostat Powder Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Hemostat Powder competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
When blood vessel walls are disrupted during surgeries, there are occurrences of blood loss, which needs to get coagulated. This process of blood clot formation at the site of injury is known as hemostasis. Hence, hemostats offer temporary blockage by forming blood clot to control bleeding.
Hemostat powder is product in form of powder.
Market competition is intense. Johnson & Johnson, C. R. Bard, Pfizer, CSL Behring and Gelita Medical, etc. are the leaders of the industry, with about 70% market shares.
North America is the largest consumption place, with a consumption market share nearly 40%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
The classification of hemostat powder includes gelatin, fibrin, cellulose and the proportion of gelatin is about 38%.
Hemostat Powder is widely used in surgical wound care and general wound care. The most proportion of hemostat powder is used in surgical wound care, and the proportion is 65%.
This report delivers a comprehensive overview of the global Hemostat Powder market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Hemostat Powder. The Hemostat Powder market size, estimates, and forecasts are provided in terms of sales volume (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Hemostat Powder market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Hemostat Powder manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Hemostat Powder Market Report

Report Metric Details
Report Name Hemostat Powder Market
Accounted market size in 2025 US$ 440 million
Forecasted market size in 2032 US$ 600 million
CAGR 4.6%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Gelatin
  • Fibrin
  • Cellulose
  • Others
by Application
  • Surgical Wound Care
  • General Wound Care
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Johnson & Johnson, C. R. Bard, Pfizer, CSL Behring, Gelita Medical, Ferrosan Medical Devices, Baxter, Celox, Equimedical, Medira, Biocer, Hemostasis, MBP
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Hemostat Powder manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Hemostat Powder sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Hemostat Powder Market growing?

Ans: The Hemostat Powder Market witnessing a CAGR of 4.6% during the forecast period 2026-2032.

What is the Hemostat Powder Market size in 2032?

Ans: The Hemostat Powder Market size in 2032 will be US$ 600 million.

What is the Johnson & Johnson, C. R. Bard, Pfizer, CSL Behring, Gelita Medical share in Hemostat Powder Market?

Ans: Johnson & Johnson, C. R. Bard, Pfizer, CSL Behring and Gelita Medical, etc. are the leaders of the industry, with about 70% market shares.

What is the Hemostat Powder Market share by region?

Ans: North America is the largest consumption place, with a consumption market share nearly 40%.

What is the Hemostat Powder Market share by application?

Ans: The most proportion of hemostat powder is used in surgical wound care, and the proportion is 65%.

Who are the main players in the Hemostat Powder Market report?

Ans: The main players in the Hemostat Powder Market are Johnson & Johnson, C. R. Bard, Pfizer, CSL Behring, Gelita Medical, Ferrosan Medical Devices, Baxter, Celox, Equimedical, Medira, Biocer, Hemostasis, MBP

What are the Application segmentation covered in the Hemostat Powder Market report?

Ans: The Applications covered in the Hemostat Powder Market report are Surgical Wound Care, General Wound Care

What are the Type segmentation covered in the Hemostat Powder Market report?

Ans: The Types covered in the Hemostat Powder Market report are Gelatin, Fibrin, Cellulose, Others

1 Hemostat Powder Market Overview
1.1 Product Definition
1.2 Hemostat Powder by Type
1.2.1 Global Hemostat Powder Market Value by Type: 2025 vs 2032
1.2.2 Gelatin
1.2.3 Fibrin
1.2.4 Cellulose
1.2.5 Others
1.3 Hemostat Powder by Application
1.3.1 Global Hemostat Powder Market Value by Application: 2025 vs 2032
1.3.2 Surgical Wound Care
1.3.3 General Wound Care
1.4 Global Hemostat Powder Market Size Estimates and Forecasts
1.4.1 Global Hemostat Powder Revenue 2021–2032
1.4.2 Global Hemostat Powder Sales 2021–2032
1.4.3 Global Hemostat Powder Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Hemostat Powder Market Competition by Manufacturers
2.1 Global Hemostat Powder Sales Market Share by Manufacturers (2021–2026)
2.2 Global Hemostat Powder Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Hemostat Powder Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Hemostat Powder, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Hemostat Powder, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Hemostat Powder, Product Types and Applications
2.7 Global Key Manufacturers of Hemostat Powder, Date of Entry into the Industry
2.8 Global Hemostat Powder Market Competitive Situation and Trends
2.8.1 Global Hemostat Powder Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Hemostat Powder Players Market Share by Revenue
2.8.3 Global Hemostat Powder Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hemostat Powder Market Scenario by Region
3.1 Global Hemostat Powder Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Hemostat Powder Sales by Region: 2021–2032
3.2.1 Global Hemostat Powder Sales by Region: 2021–2026
3.2.2 Global Hemostat Powder Sales by Region: 2027–2032
3.3 Global Hemostat Powder Revenue by Region: 2021–2032
3.3.1 Global Hemostat Powder Revenue by Region: 2021–2026
3.3.2 Global Hemostat Powder Revenue by Region: 2027–2032
3.4 North America Hemostat Powder Market Facts & Figures by Country
3.4.1 North America Hemostat Powder Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Hemostat Powder Sales by Country (2021–2032)
3.4.3 North America Hemostat Powder Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hemostat Powder Market Facts & Figures by Country
3.5.1 Europe Hemostat Powder Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Hemostat Powder Sales by Country (2021–2032)
3.5.3 Europe Hemostat Powder Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hemostat Powder Market Facts & Figures by Region
3.6.1 Asia Pacific Hemostat Powder Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Hemostat Powder Sales by Region (2021–2032)
3.6.3 Asia Pacific Hemostat Powder Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Hemostat Powder Market Facts & Figures by Country
3.7.1 Latin America Hemostat Powder Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Hemostat Powder Sales by Country (2021–2032)
3.7.3 Latin America Hemostat Powder Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hemostat Powder Market Facts & Figures by Country
3.8.1 Middle East and Africa Hemostat Powder Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Hemostat Powder Sales by Country (2021–2032)
3.8.3 Middle East and Africa Hemostat Powder Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Hemostat Powder Sales by Type (2021–2032)
4.1.1 Global Hemostat Powder Sales by Type (2021–2026)
4.1.2 Global Hemostat Powder Sales by Type (2027–2032)
4.1.3 Global Hemostat Powder Sales Market Share by Type (2021–2032)
4.2 Global Hemostat Powder Revenue by Type (2021–2032)
4.2.1 Global Hemostat Powder Revenue by Type (2021–2026)
4.2.2 Global Hemostat Powder Revenue by Type (2027–2032)
4.2.3 Global Hemostat Powder Revenue Market Share by Type (2021–2032)
4.3 Global Hemostat Powder Price by Type (2021–2032)
5 Segment by Application
5.1 Global Hemostat Powder Sales by Application (2021–2032)
5.1.1 Global Hemostat Powder Sales by Application (2021–2026)
5.1.2 Global Hemostat Powder Sales by Application (2027–2032)
5.1.3 Global Hemostat Powder Sales Market Share by Application (2021–2032)
5.2 Global Hemostat Powder Revenue by Application (2021–2032)
5.2.1 Global Hemostat Powder Revenue by Application (2021–2026)
5.2.2 Global Hemostat Powder Revenue by Application (2027–2032)
5.2.3 Global Hemostat Powder Revenue Market Share by Application (2021–2032)
5.3 Global Hemostat Powder Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Company Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Hemostat Powder Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Johnson & Johnson Hemostat Powder Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 C. R. Bard
6.2.1 C. R. Bard Company Information
6.2.2 C. R. Bard Description and Business Overview
6.2.3 C. R. Bard Hemostat Powder Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 C. R. Bard Hemostat Powder Product Portfolio
6.2.5 C. R. Bard Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Company Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Hemostat Powder Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Pfizer Hemostat Powder Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 CSL Behring
6.4.1 CSL Behring Company Information
6.4.2 CSL Behring Description and Business Overview
6.4.3 CSL Behring Hemostat Powder Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 CSL Behring Hemostat Powder Product Portfolio
6.4.5 CSL Behring Recent Developments/Updates
6.5 Gelita Medical
6.5.1 Gelita Medical Company Information
6.5.2 Gelita Medical Description and Business Overview
6.5.3 Gelita Medical Hemostat Powder Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Gelita Medical Hemostat Powder Product Portfolio
6.5.5 Gelita Medical Recent Developments/Updates
6.6 Ferrosan Medical Devices
6.6.1 Ferrosan Medical Devices Company Information
6.6.2 Ferrosan Medical Devices Description and Business Overview
6.6.3 Ferrosan Medical Devices Hemostat Powder Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Ferrosan Medical Devices Hemostat Powder Product Portfolio
6.6.5 Ferrosan Medical Devices Recent Developments/Updates
6.7 Baxter
6.7.1 Baxter Company Information
6.7.2 Baxter Description and Business Overview
6.7.3 Baxter Hemostat Powder Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Baxter Hemostat Powder Product Portfolio
6.7.5 Baxter Recent Developments/Updates
6.8 Celox
6.8.1 Celox Company Information
6.8.2 Celox Description and Business Overview
6.8.3 Celox Hemostat Powder Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Celox Hemostat Powder Product Portfolio
6.8.5 Celox Recent Developments/Updates
6.9 Equimedical
6.9.1 Equimedical Company Information
6.9.2 Equimedical Description and Business Overview
6.9.3 Equimedical Hemostat Powder Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Equimedical Hemostat Powder Product Portfolio
6.9.5 Equimedical Recent Developments/Updates
6.10 Medira
6.10.1 Medira Company Information
6.10.2 Medira Description and Business Overview
6.10.3 Medira Hemostat Powder Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Medira Hemostat Powder Product Portfolio
6.10.5 Medira Recent Developments/Updates
6.11 Biocer
6.11.1 Biocer Company Information
6.11.2 Biocer Description and Business Overview
6.11.3 Biocer Hemostat Powder Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Biocer Hemostat Powder Product Portfolio
6.11.5 Biocer Recent Developments/Updates
6.12 Hemostasis
6.12.1 Hemostasis Company Information
6.12.2 Hemostasis Description and Business Overview
6.12.3 Hemostasis Hemostat Powder Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Hemostasis Hemostat Powder Product Portfolio
6.12.5 Hemostasis Recent Developments/Updates
6.13 MBP
6.13.1 MBP Company Information
6.13.2 MBP Description and Business Overview
6.13.3 MBP Hemostat Powder Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 MBP Hemostat Powder Product Portfolio
6.13.5 MBP Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hemostat Powder Industry Chain Analysis
7.2 Hemostat Powder Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hemostat Powder Production Mode & Process Analysis
7.4 Hemostat Powder Sales and Marketing
7.4.1 Hemostat Powder Sales Channels
7.4.2 Hemostat Powder Distributors
7.5 Hemostat Powder Customer Analysis
8 Hemostat Powder Market Dynamics
8.1 Hemostat Powder Industry Trends
8.2 Hemostat Powder Market Drivers
8.3 Hemostat Powder Market Challenges
8.4 Hemostat Powder Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Hemostat Powder Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Hemostat Powder Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Hemostat Powder Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Hemostat Powder Sales (K MT) of Key Manufacturers (2021–2026)
 Table 5. Global Hemostat Powder Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Hemostat Powder Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Hemostat Powder Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Hemostat Powder Average Price (USD/MT) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Hemostat Powder, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Hemostat Powder, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Hemostat Powder, Product Types and Applications
 Table 12. Global Key Manufacturers of Hemostat Powder, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Hemostat Powder Companies by Tier (Tier 1, Tier 2, Tier 3), based on Hemostat Powder Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Hemostat Powder Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Hemostat Powder Sales by Region (K MT), 2021–2026
 Table 18. Global Hemostat Powder Sales Market Share by Region (2021–2026)
 Table 19. Global Hemostat Powder Sales by Region (K MT), 2027–2032
 Table 20. Global Hemostat Powder Sales Market Share by Region (2027–2032)
 Table 21. Global Hemostat Powder Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Hemostat Powder Revenue Market Share by Region (2021–2026)
 Table 23. Global Hemostat Powder Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Hemostat Powder Revenue Market Share by Region (2027–2032)
 Table 25. North America Hemostat Powder Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Hemostat Powder Sales by Country (K MT), 2021–2026
 Table 27. North America Hemostat Powder Sales by Country (K MT), 2027–2032
 Table 28. North America Hemostat Powder Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Hemostat Powder Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Hemostat Powder Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Hemostat Powder Sales by Country (K MT), 2021–2026
 Table 32. Europe Hemostat Powder Sales by Country (K MT), 2027–2032
 Table 33. Europe Hemostat Powder Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Hemostat Powder Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Hemostat Powder Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Hemostat Powder Sales by Region (K MT), 2021–2026
 Table 37. Asia Pacific Hemostat Powder Sales by Region (K MT), 2027–2032
 Table 38. Asia Pacific Hemostat Powder Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Hemostat Powder Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Hemostat Powder Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Hemostat Powder Sales by Country (K MT), 2021–2026
 Table 42. Latin America Hemostat Powder Sales by Country (K MT), 2027–2032
 Table 43. Latin America Hemostat Powder Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Hemostat Powder Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Hemostat Powder Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Hemostat Powder Sales by Country (K MT), 2021–2026
 Table 47. Middle East and Africa Hemostat Powder Sales by Country (K MT), 2027–2032
 Table 48. Middle East and Africa Hemostat Powder Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Hemostat Powder Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Hemostat Powder Sales (K MT) by Type (2021–2026)
 Table 51. Global Hemostat Powder Sales (K MT) by Type (2027–2032)
 Table 52. Global Hemostat Powder Sales Market Share by Type (2021–2026)
 Table 53. Global Hemostat Powder Sales Market Share by Type (2027–2032)
 Table 54. Global Hemostat Powder Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Hemostat Powder Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Hemostat Powder Revenue Market Share by Type (2021–2026)
 Table 57. Global Hemostat Powder Revenue Market Share by Type (2027–2032)
 Table 58. Global Hemostat Powder Price (USD/MT) by Type (2021–2026)
 Table 59. Global Hemostat Powder Price (USD/MT) by Type (2027–2032)
 Table 60. Global Hemostat Powder Sales (K MT) by Application (2021–2026)
 Table 61. Global Hemostat Powder Sales (K MT) by Application (2027–2032)
 Table 62. Global Hemostat Powder Sales Market Share by Application (2021–2026)
 Table 63. Global Hemostat Powder Sales Market Share by Application (2027–2032)
 Table 64. Global Hemostat Powder Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Hemostat Powder Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Hemostat Powder Revenue Market Share by Application (2021–2026)
 Table 67. Global Hemostat Powder Revenue Market Share by Application (2027–2032)
 Table 68. Global Hemostat Powder Price (USD/MT) by Application (2021–2026)
 Table 69. Global Hemostat Powder Price (USD/MT) by Application (2027–2032)
 Table 70. Johnson & Johnson Company Information
 Table 71. Johnson & Johnson Description and Business Overview
 Table 72. Johnson & Johnson Hemostat Powder Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 73. Johnson & Johnson Hemostat Powder Product
 Table 74. Johnson & Johnson Recent Developments/Updates
 Table 75. C. R. Bard Company Information
 Table 76. C. R. Bard Description and Business Overview
 Table 77. C. R. Bard Hemostat Powder Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 78. C. R. Bard Hemostat Powder Product
 Table 79. C. R. Bard Recent Developments/Updates
 Table 80. Pfizer Company Information
 Table 81. Pfizer Description and Business Overview
 Table 82. Pfizer Hemostat Powder Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 83. Pfizer Hemostat Powder Product
 Table 84. Pfizer Recent Developments/Updates
 Table 85. CSL Behring Company Information
 Table 86. CSL Behring Description and Business Overview
 Table 87. CSL Behring Hemostat Powder Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 88. CSL Behring Hemostat Powder Product
 Table 89. CSL Behring Recent Developments/Updates
 Table 90. Gelita Medical Company Information
 Table 91. Gelita Medical Description and Business Overview
 Table 92. Gelita Medical Hemostat Powder Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 93. Gelita Medical Hemostat Powder Product
 Table 94. Gelita Medical Recent Developments/Updates
 Table 95. Ferrosan Medical Devices Company Information
 Table 96. Ferrosan Medical Devices Description and Business Overview
 Table 97. Ferrosan Medical Devices Hemostat Powder Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 98. Ferrosan Medical Devices Hemostat Powder Product
 Table 99. Ferrosan Medical Devices Recent Developments/Updates
 Table 100. Baxter Company Information
 Table 101. Baxter Description and Business Overview
 Table 102. Baxter Hemostat Powder Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 103. Baxter Hemostat Powder Product
 Table 104. Baxter Recent Developments/Updates
 Table 105. Celox Company Information
 Table 106. Celox Description and Business Overview
 Table 107. Celox Hemostat Powder Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 108. Celox Hemostat Powder Product
 Table 109. Celox Recent Developments/Updates
 Table 110. Equimedical Company Information
 Table 111. Equimedical Description and Business Overview
 Table 112. Equimedical Hemostat Powder Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 113. Equimedical Hemostat Powder Product
 Table 114. Equimedical Recent Developments/Updates
 Table 115. Medira Company Information
 Table 116. Medira Description and Business Overview
 Table 117. Medira Hemostat Powder Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 118. Medira Hemostat Powder Product
 Table 119. Medira Recent Developments/Updates
 Table 120. Biocer Company Information
 Table 121. Biocer Description and Business Overview
 Table 122. Biocer Hemostat Powder Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 123. Biocer Hemostat Powder Product
 Table 124. Biocer Recent Developments/Updates
 Table 125. Hemostasis Company Information
 Table 126. Hemostasis Description and Business Overview
 Table 127. Hemostasis Hemostat Powder Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 128. Hemostasis Hemostat Powder Product
 Table 129. Hemostasis Recent Developments/Updates
 Table 130. MBP Company Information
 Table 131. MBP Description and Business Overview
 Table 132. MBP Hemostat Powder Sales (K MT), Revenue (US$ Million), Price (USD/MT), and Gross Margin (2021–2026)
 Table 133. MBP Hemostat Powder Product
 Table 134. MBP Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Hemostat Powder Distributors List
 Table 138. Hemostat Powder Customers List
 Table 139. Hemostat Powder Market Trends
 Table 140. Hemostat Powder Market Drivers
 Table 141. Hemostat Powder Market Challenges
 Table 142. Hemostat Powder Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Hemostat Powder
 Figure 2. Global Hemostat Powder Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Hemostat Powder Market Share by Type: 2025 & 2032
 Figure 4. Gelatin Product Picture
 Figure 5. Fibrin Product Picture
 Figure 6. Cellulose Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Hemostat Powder Market Value by Application (US$ Million), 2021–2032
 Figure 9. Global Hemostat Powder Market Share by Application: 2025 & 2032
 Figure 10. Surgical Wound Care
 Figure 11. General Wound Care
 Figure 12. Global Hemostat Powder Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Hemostat Powder Market Size (US$ Million), 2021–2032
 Figure 14. Global Hemostat Powder Sales (K MT), 2021–2032
 Figure 15. Global Hemostat Powder Average Price (USD/MT), 2021–2032
 Figure 16. Hemostat Powder Report Years Considered
 Figure 17. Hemostat Powder Sales Share by Manufacturers in 2025
 Figure 18. Global Hemostat Powder Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Hemostat Powder Players: Market Share by Revenue in Hemostat Powder in 2025
 Figure 20. Hemostat Powder Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Hemostat Powder Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Hemostat Powder Sales Market Share by Country (2021–2032)
 Figure 23. North America Hemostat Powder Revenue Market Share by Country (2021–2032)
 Figure 24. U.S. Hemostat Powder Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Hemostat Powder Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Hemostat Powder Sales Market Share by Country (2021–2032)
 Figure 27. Europe Hemostat Powder Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Hemostat Powder Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Hemostat Powder Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Hemostat Powder Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Hemostat Powder Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Hemostat Powder Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Hemostat Powder Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Hemostat Powder Revenue Market Share by Region (2021–2032)
 Figure 35. China Hemostat Powder Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Hemostat Powder Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Hemostat Powder Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Hemostat Powder Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Hemostat Powder Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Taiwan Hemostat Powder Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Indonesia Hemostat Powder Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Thailand Hemostat Powder Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Malaysia Hemostat Powder Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Philippines Hemostat Powder Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Latin America Hemostat Powder Sales Market Share by Country (2021–2032)
 Figure 46. Latin America Hemostat Powder Revenue Market Share by Country (2021–2032)
 Figure 47. Mexico Hemostat Powder Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Brazil Hemostat Powder Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Argentina Hemostat Powder Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Middle East and Africa Hemostat Powder Sales Market Share by Country (2021–2032)
 Figure 51. Middle East and Africa Hemostat Powder Revenue Market Share by Country (2021–2032)
 Figure 52. Turkey Hemostat Powder Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Saudi Arabia Hemostat Powder Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. U.A.E Hemostat Powder Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Global Sales Market Share of Hemostat Powder by Type (2021–2032)
 Figure 56. Global Revenue Market Share of Hemostat Powder by Type (2021–2032)
 Figure 57. Global Hemostat Powder Price (USD/MT) by Type (2021–2032)
 Figure 58. Global Sales Market Share of Hemostat Powder by Application (2021–2032)
 Figure 59. Global Revenue Market Share of Hemostat Powder by Application (2021–2032)
 Figure 60. Global Hemostat Powder Price (USD/MT) by Application (2021–2032)
 Figure 61. Hemostat Powder Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS